A detailed history of Qsemble Capital Management, LP transactions in Incyte Corp stock. As of the latest transaction made, Qsemble Capital Management, LP holds 55,114 shares of INCY stock, worth $4.54 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
55,114
Holding current value
$4.54 Million
% of portfolio
0.63%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$51.18 - $63.75 $2.82 Million - $3.51 Million
55,114 New
55,114 $3.34 Billion
Q4 2023

Feb 07, 2024

SELL
$52.16 - $64.19 $3.54 Million - $4.36 Million
-67,861 Reduced 88.59%
8,739 $549 Million
Q3 2023

Nov 07, 2023

BUY
$57.77 - $65.93 $4.43 Million - $5.05 Million
76,600 New
76,600 $4.43 Billion
Q1 2023

May 10, 2023

BUY
$70.23 - $86.01 $217,713 - $266,631
3,100 Added 24.8%
15,600 $1.13 Billion
Q4 2022

Feb 09, 2023

BUY
$67.18 - $84.11 $839,750 - $1.05 Million
12,500 New
12,500 $1 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $18.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Qsemble Capital Management, LP Portfolio

Follow Qsemble Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qsemble Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Qsemble Capital Management, LP with notifications on news.